NO20002990L - Nytt overflateprotein - Google Patents

Nytt overflateprotein

Info

Publication number
NO20002990L
NO20002990L NO20002990A NO20002990A NO20002990L NO 20002990 L NO20002990 L NO 20002990L NO 20002990 A NO20002990 A NO 20002990A NO 20002990 A NO20002990 A NO 20002990A NO 20002990 L NO20002990 L NO 20002990L
Authority
NO
Norway
Prior art keywords
surface protein
new surface
new
protein
Prior art date
Application number
NO20002990A
Other languages
English (en)
Norwegian (no)
Other versions
NO20002990D0 (no
Inventor
Ian Richard Anselm Peak
Michael Paul Jennings
E Richard Moxon
Original Assignee
Univ Queensland
Isis Innovation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10823587&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20002990(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Queensland, Isis Innovation filed Critical Univ Queensland
Publication of NO20002990D0 publication Critical patent/NO20002990D0/no
Publication of NO20002990L publication Critical patent/NO20002990L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20002990A 1997-12-12 2000-06-09 Nytt overflateprotein NO20002990L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9726398.2A GB9726398D0 (en) 1997-12-12 1997-12-12 Polypeptide and coding sequences
PCT/AU1998/001031 WO1999031132A1 (en) 1997-12-12 1998-12-14 NOVEL SURFACE PROTEIN OF $i(NEISSERIA MENINGITIDIS)

Publications (2)

Publication Number Publication Date
NO20002990D0 NO20002990D0 (no) 2000-06-09
NO20002990L true NO20002990L (no) 2000-08-08

Family

ID=10823587

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002990A NO20002990L (no) 1997-12-12 2000-06-09 Nytt overflateprotein

Country Status (17)

Country Link
US (8) US6197312B1 (cs)
EP (2) EP2354230A1 (cs)
JP (2) JP4356961B2 (cs)
KR (1) KR100571533B1 (cs)
CN (2) CN101684148A (cs)
AU (1) AU747742B2 (cs)
BR (1) BR9814276A (cs)
CA (1) CA2314319C (cs)
CZ (1) CZ299646B6 (cs)
GB (1) GB9726398D0 (cs)
HU (1) HUP0100094A3 (cs)
IL (2) IL136684A0 (cs)
NO (1) NO20002990L (cs)
NZ (1) NZ505374A (cs)
PL (1) PL205984B1 (cs)
TR (1) TR200001709T2 (cs)
WO (1) WO1999031132A1 (cs)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726398D0 (en) 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
CN1224708C (zh) * 1998-01-14 2005-10-26 启龙股份公司 脑膜炎奈瑟氏球菌抗原
FR2776928B1 (fr) * 1998-04-03 2000-06-23 Merial Sas Vaccins adn adjuves
BR9910089A (pt) 1998-05-01 2004-06-08 Chiron Corp Composições e antìgenos de neisseria meningitidis
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
PT1228217E (pt) * 1999-04-30 2013-01-28 Novartis Vaccines & Diagnostic Antígenos de neisseria conservados
AU2004240199B2 (en) * 1999-04-30 2007-05-17 Novartis Vaccines And Diagnostics S.R.L. Conserved Neisserial antigens
EP1173578A2 (en) * 1999-05-04 2002-01-23 Monsanto Company Coleopteran-toxic polypeptide compositions and insect-resistant transgenic plants
CA2838395C (en) * 1999-05-19 2016-07-19 Novartis Vaccines And Diagnostics S.R.L. Combination neisserial compositions
GB9916529D0 (en) * 1999-07-14 1999-09-15 Chiron Spa Antigenic peptides
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
ES2564463T3 (es) * 1999-10-29 2016-03-22 Glaxosmithkline Biologicals S.A. Péptidos antigénicos de Neisseriales
GB9928196D0 (en) 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
JP4840956B2 (ja) 1999-11-29 2011-12-21 ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル ８５ｋＤａのナイセリア抗原
EP2275129A3 (en) * 2000-01-17 2013-11-06 Novartis Vaccines and Diagnostics S.r.l. Outer membrane vesicle (OMV) vaccine comprising N. meningitidis serogroup B outer membrane proteins
MXPA02007184A (es) * 2000-01-25 2004-02-26 Univ Queensland Proteinas que comprenden regiones conservadas de antigenos de superficie nhha de neisseria meningitidis.
AU2005202972B2 (en) * 2000-01-25 2008-04-24 The University Of Queensland Proteins comprising conserved regions of neisseria meningitidis surface antigen NhhA
CN1201011C (zh) 2000-02-28 2005-05-11 启龙股份公司 奈瑟球菌蛋白质的异源表达
NO20002828D0 (no) * 2000-06-02 2000-06-02 Statens Inst For Folkehelse Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
GB0121591D0 (en) 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
ATE469915T1 (de) 2001-07-27 2010-06-15 Novartis Vaccines & Diagnostic Antikörper gegen das meningokokken adhäsin app
GB0129007D0 (en) * 2001-12-04 2002-01-23 Chiron Spa Adjuvanted antigenic meningococcal compositions
BR0313100A (pt) * 2002-08-02 2005-06-21 Glaxosmithkline Biolog Sa Composição imunogênica, composição imunogênica isolada, vacina, método de tratamento ou prevenção de doença bacteriana gram-negativa, uso da vacina, cepa bacteriana gram-negativa geneticamente manipulada, método para preparar a composição imunogênica, método para preparar a vacina, método de preparar uma imunoglobulina para uso na prevenção ou tratamento de infecção neisserial, preparação de imunoglobulina, preparação farmacêutica, e, uso da preparação farmacêutica
KR20050039839A (ko) * 2002-08-02 2005-04-29 글락소스미스클라인 바이오로지칼즈 에스.에이. Ｌｇｔｂ- 나이세리아 메닌기티디스로부터의 ｌ2 및/또는ｌ3 면역유형 리포올리고사카라이드를 포함하는 백신 조성물
ES2608048T3 (es) 2002-10-11 2017-04-05 Glaxosmithkline Biologicals Sa Vacunas polipeptídicas para protección amplia contra linajes meningocócicos hipervirulentos
PT2395073T (pt) 2002-11-01 2017-11-24 Glaxosmithkline Biologicals Sa Processo de secagem
AU2004277342B2 (en) 2003-10-02 2010-12-16 Glaxosmithkline Biologicals S.A. Pertussis antigens and use thereof in vaccination
DE602004032481D1 (de) 2003-10-02 2011-06-09 Novartis Vaccines & Diagnostic Kombinationsimpfstoffe gegen Meningitis
GB0408977D0 (en) 2004-04-22 2004-05-26 Chiron Srl Immunising against meningococcal serogroup Y using proteins
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
TW200800235A (en) * 2005-10-18 2008-01-01 Otsuka Pharma Co Ltd Carrier composition for nucleic acid transport
JP5275982B2 (ja) 2006-06-12 2013-08-28 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
GB0700562D0 (en) 2007-01-11 2007-02-21 Novartis Vaccines & Diagnostic Modified Saccharides
US20090139134A1 (en) 2007-10-04 2009-06-04 Bio Architecture Lab, Inc. Biofuel production
JP5117576B2 (ja) * 2007-11-19 2013-01-16 ザ プロクター アンド ギャンブル カンパニー ウェブを活性化するための装置
WO2009097346A2 (en) * 2008-01-28 2009-08-06 Bio Architecture Lab, Inc. Isolated alcohol dehydrogenase enzymes and uses thereof
US9387239B2 (en) 2008-05-30 2016-07-12 U.S. Army Medical Research And Materiel Command Meningococcal multivalent native outer membrane vesicle vaccine, methods of making and use thereof
EP2544712A1 (en) 2010-03-10 2013-01-16 GlaxoSmithKline Biologicals S.A. Immunogenic composition
BR112012022800A2 (pt) 2010-03-11 2018-05-15 Glaxosmithkline Biologicals Sa composição imunogênica ou vacina, cepa bacteriana gram-negativa geneticamente engenheirada, métodos para o tratamento ou prevenção de infecção ou doença, para produzir uma composição imunogênica ou uma vacina, e para preparar uma imunoglobulina, preparação da imunoglobulina, e, preparação farmacêutica
GB201015132D0 (en) 2010-09-10 2010-10-27 Univ Bristol Vaccine composition
WO2012032498A2 (en) 2010-09-10 2012-03-15 Novartis Ag Developments in meningococcal outer membrane vesicles
BR112014031386A2 (pt) 2012-06-14 2017-08-01 Pasteur Institut vacinas para meningococos do sorogrupo x
CZ304288B6 (cs) * 2013-06-12 2014-02-12 Rieter Cz S.R.O. Způsob a zařízení ke sledování lineárního útvaru

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849338A (en) 1982-07-16 1989-07-18 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
US4843000A (en) 1979-12-26 1989-06-27 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
US4550081A (en) 1980-05-19 1985-10-29 The Board Of Trustees Of The Leland Stanford Jr. University Non-reverting salmonella
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4769240A (en) * 1980-09-15 1988-09-06 Bactex, Inc. Pili of neisseria and vaccine compositions containing same
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
US4603112A (en) 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
US4702911A (en) * 1985-09-27 1987-10-27 Immunomed Corporation Preparation of bacterium pili subunits and vaccines containing pili subunits
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5091513A (en) 1987-05-21 1992-02-25 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
JPH01125328A (ja) 1987-07-30 1989-05-17 Centro Natl De Biopreparados 髄膜炎菌ワクチン
US5785973A (en) 1988-02-01 1998-07-28 Praxis Biologics, Inc. Synthetic peptides representing a T-cell epitope as a carrier molecule for conjugate vaccines
EP0407413B1 (de) 1988-03-24 1992-06-03 ZACH, Johann Druck- oder kraftmessvorrichtung
ATE439859T1 (de) * 1990-08-23 2009-09-15 Univ North Carolina Transferrin bindende proteine aus neisseria- gonorrhoeae und neisseria-meningitidis. ihre verwendung in einem impfstoff
FR2682041B1 (fr) 1991-10-03 1994-01-14 Pasteur Merieux Serums Vaccins Vaccin contre les infections a neisseria meningitidis.
US5422252A (en) 1993-06-04 1995-06-06 Becton, Dickinson And Company Simultaneous amplification of multiple targets
IL117483A (en) * 1995-03-17 2008-03-20 Bernard Brodeur MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
US5646259A (en) * 1995-03-24 1997-07-08 St. Louis University DNA encoding haemophilus adhesion proteins
DK0862656T3 (da) 1995-11-21 2001-04-09 Univ Yale Unimolekylær segmentamplifikation og -detektering
CU22559A1 (es) 1996-01-17 1999-05-03 Ct Ingenieria Genetica Biotech Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión
GB9726398D0 (en) 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
CN1224708C (zh) * 1998-01-14 2005-10-26 启龙股份公司 脑膜炎奈瑟氏球菌抗原
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds

Also Published As

Publication number Publication date
US6197312B1 (en) 2001-03-06
TR200001709T2 (tr) 2001-03-21
NO20002990D0 (no) 2000-06-09
CN101684148A (zh) 2010-03-31
KR20010033074A (ko) 2001-04-25
BR9814276A (pt) 2000-10-03
US20100331537A1 (en) 2010-12-30
JP2009045071A (ja) 2009-03-05
US8034358B2 (en) 2011-10-11
PL341160A1 (en) 2001-03-26
CZ20002172A3 (cs) 2000-11-15
US6607729B2 (en) 2003-08-19
IL136684A0 (en) 2001-06-14
US20130085262A1 (en) 2013-04-04
US20120123093A1 (en) 2012-05-17
GB9726398D0 (en) 1998-02-11
EP2354230A1 (en) 2011-08-10
CA2314319C (en) 2013-08-13
CZ299646B6 (cs) 2008-10-01
JP4356961B2 (ja) 2009-11-04
EP1045859A4 (en) 2001-08-22
US6495345B1 (en) 2002-12-17
HUP0100094A3 (en) 2003-08-28
WO1999031132A1 (en) 1999-06-24
IL199175A (en) 2013-07-31
AU1649599A (en) 1999-07-05
JP2002508394A (ja) 2002-03-19
NZ505374A (en) 2002-03-01
CA2314319A1 (en) 1999-06-24
US20050058660A1 (en) 2005-03-17
JP4651703B2 (ja) 2011-03-16
EP1045859A1 (en) 2000-10-25
CN1284965A (zh) 2001-02-21
KR100571533B1 (ko) 2006-04-14
US8067004B2 (en) 2011-11-29
US20020102276A1 (en) 2002-08-01
AU747742B2 (en) 2002-05-23
PL205984B1 (pl) 2010-06-30
US20090270591A1 (en) 2009-10-29
HUP0100094A1 (hu) 2001-05-28

Similar Documents

Publication Publication Date Title
NO20002990L (no) Nytt overflateprotein
DE19810476B4 (de) Laryngomaske
ATA93198A (de) Fluoxetinpellets
DE69815952D1 (de) Poliergerät
PT1036083E (pt) Novos 9a-azalidos
DE69816146D1 (de) Poliervorrichtung
DE59803185D1 (de) Baulaser
ATA111897A (de) Kimme
DE59802506D1 (de) Weichspülmittelzusammemsetzung
DE69838161D1 (de) Poliervorrichtung
DE59710388D1 (de) Mikropolarimeter
DE59801498D1 (de) Dioxacycloalkan-8-one
DE69925271D1 (de) Angiostatin-bindendes protein
DK0983266T3 (da) Hidtil ukendte tetrahydrosioquinolinthiophencarboximidamider
ATA112597A (de) Snowboard - bindung
EP0949331A4 (en) Established microglial cells
DK1005511T3 (da) Overfladebehandling
ATA86797A (de) Verschleissschuh
DE59800820D1 (de) Stiellose kniegelenkendoprothese
BR9701194A (pt) Hidrociclo
ATA46498A (de) Kunststoffgleitbahn
FI970511A0 (fi) Lutbart plan
ITMI972543A1 (it) Proteina p27bbp
DK1088069T3 (da) Angiostatin-bindende protein
SE9702094D0 (sv) Kantblock

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application